FIGURE

Fig. 13

ID

ZDB-FIG-250807-70

Publication

Misra et al., 2025 - Tirzepatide mitigates cognitive decline in zebrafish model of type 2 diabetes mellitus induced by high-fat diet

Other Figures

All Figure Page

Back to All Figure Page

Fig. 13

Effect of TZP on level of Bax and Bcl-2 in zebrafish in old and young age groups. A Bcl-2; B Bax. The level of Bax was significantly decreased in the TZP treated group as compared with the HFD group and Bcl-2 level was improved in TZP treated groups as compared to the HFD group. The statistical data analysis is presented by two-way ANOVA analysis by employing the Bonferroni post-test. Values presented as mean ± SD (p < 0.05), a vs. control, TZP (10 nM) per se, a vs. HFD, b vs. HFD + TZP (10 nM), c vs. HFD + DPZ (5 mg/kg). Values presented as mean ± SD (p < 0.05), α vs. HFD (young age group), β vs. HFD + TZP (young age group), (n = 3). A [F (4, 20) = 1.21, p = 0.0001], B [F (4, 20) = 2.35, p = 0.3377]

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Naunyn-Schmiedeberg's Arch. Pharmacol.